Lexicon Pharmaceuticals
LXRX
#7250
Rank
C$0.66 B
Marketcap
C$1.82
Share price
0.36%
Change (1 day)
76.37%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): C-$0.27

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$0.26. In 2024 the company made an earnings per share (EPS) of C-$0.88 an increase over its 2023 EPS that were of C-$1.10.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.27-69.15%
2024C-$0.88-20%
2023C-$1.1031.15%
2022C-$0.84-0%
2021C-$0.8410.91%
2020C-$0.76-145.08%
2019C$1.68-206.09%
2018C-$1.58-5.74%
2017C-$1.68-10.95%
2016C-$1.892640%
2015C-$0.06888-96.34%
2014C-$1.88-2.53%
2013C-$1.93-9.09%
2012C-$2.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
C-$105.68 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$59.84-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.18 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$3.75-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$23.89-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.74 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$6.16-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$3.29-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C-$1.03 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA